This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Latest Version Of Operetta's Software, Harmony 3.5, Enables Scientists To Track Individual Cells Over Time For A Better Understanding Of Dynamic Processes And To Generate More Accurate Prediction Models. (Photo: Business Wire)

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, has announced enhancements for its Operetta ® High Content Imaging System, designed to significantly improve the ability of scientists to perform live cell assays with higher throughput, to help foster a better understanding of normal and aberrant cellular behavior.
The latest version of Operetta's software, Harmony 3.5, enables scientists to track individual cells ...

The latest version of Operetta's software, Harmony 3.5, enables scientists to track individual cells over time for a better understanding of dynamic processes and to generate more accurate prediction models. (Photo: Business Wire)

Scientists conducting research in the areas of cancer, stem cells or infectious diseases will benefit from the Operetta system’s new capabilities to analyze the dynamic behavior of cells using advanced live cell, high content imaging. With the new capabilities, users will be able to accurately observe individual cell behavior over time to better understand dynamic processes in order to generate more accurate prediction models, for example how cancer cells migrate during metastasis or how viruses invade cells.

“We are seeing a trend towards researchers using biological assays that are better models of the physiological environment in vivo earlier in the drug discovery process in order to improve the likelihood of a drug succeeding at clinical trial.” said Jim Corbett, President, Diagnostics and Life Sciences, PerkinElmer. “With these new live cell imaging capabilities, our customers will have easy access to a wider range of applications than ever before and will be able to generate more biologically relevant data on how cells respond to compounds, helping to reduce false positives later in the drug discovery process.”

The Operetta system’s new capabilities include brightfield imaging and environmental chamber options, and a new transmitted light digital phase-contrast mode that enables users to image and segment live cells without using fluorescent dyes. This feature reduces toxic effects of nuclear stains that may negatively impact the viability of cells, enabling longer and more predictive live cell studies. Furthermore, it can help to reduce assay costs.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 0.00%
FB $118.06 0.00%
GOOG $695.70 0.00%
TSLA $222.56 0.00%
YHOO $36.00 0.00%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs